The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1555
ISSUE1555
September 10, 2018
A Mometasone-Eluting Sinus Implant (Sinuva) for Nasal Polyps
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
A Mometasone-Eluting Sinus Implant (Sinuva) for Nasal Polyps
September 10, 2018 (Issue: 1555)
The FDA has approved Sinuva (Intersect ENT), a sinus
implant that gradually releases the corticosteroid
mometasone furoate over a 90-day period, for
treatment of nasal polyps in adults who have had
ethmoid sinus surgery. Propel, a sinus implant...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.